ABBOTT PARK, Ill. -
The expanded coverage will enable more people with diabetes to access the glucose data needed to manage their condition without the routine fingersticks1 associated with traditional blood glucose monitoring.
'The best healthcare solution is the one that helps the most people, which is why we designed our FreeStyle Libre system with access and affordability in mind from the very beginning,' said
The reimbursement expansion, which will go into effect
'With the expanded reimbursement coverage, healthcare professionals like me will be equipped with continuous glucose monitoring information and actionable insights for patients with diabetes, which has previously been available mainly to a limited population of people who require multiple daily injections of insulin. This will allow patients to have a better understanding and control of their diabetes based on glucose fluctuation through continuous monitoring,' said Dr.
About
Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.
1. A fingerstick test using a blood glucose meter is required when there are questions on the accuracy of the interstitial fluid glucose levels or impending hypoglycaemia or hypoglycaemia as reported by the system or when symptoms do not match the system readings.
2. Miller, Brandner et al. HbA1c Reduction After Initiation of the FreeStyle Libre System in Type 2 Diabetes Patients on Long-Acting Insulin or Non-Insulin Therapy.
3. Miller et al. FreeStyle Libre System Use Associated with Reduction in Acute Diabetes Events and All-Cause Hospitalizations in Patients with Type 2 Diabetes Without Bolus Insulin.
4. Wright et al. HbA1c Reduction Associated with a FreeStyle Libre System in People with Type 2 Diabetes Not on Bolus Insulin Therapy.
Contact:
Abbott Media
T: 510-239-2765
Abbott Financial
T: 202-213-5129
(C) 2022 Electronic News Publishing, source